FDA Panel Discussing VIVUS's (VVUS) Qnexa...
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
An FDA advisory panel has just begun discussing VIVUS's (Nasdaq: VVUS) diet pill Qnexa. The stock was halted early this morning ahead of the panel meeting, and has yet to trade Wednesday.
Details will be given as they come.
Details will be given as they come.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- Nucor (NUE) files mixed shelf
- RenX Enterprises agrees to sell Georgia property for $2.6M
Create E-mail Alert Related Categories
Corporate News, FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
